Skip to main content
SpringerLink
Log in

Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Pre-diabetic state is a major risk factor for the development of diabetes and cardiovascular events. Admission glucose, fasting glucose and HbA1c levels have an effect on prognosis in patients with pre-diabetes and in non-diabetic individuals. The aim of the present study was to investigate which of the following glucometabolic markers (admission glucose, fasting glucose and HbA1c levels) is correlated with the severity of coronary artery disease (CAD) in non-diabetic patients.

Methods

CAD severity according to SYNTAX score was prospectively evaluated in 226 non-diabetic patients hospitalized with myocardial infarction or stable angina and underwent coronary angiography. Glucose intolerance was assessed by serum admission glucose, fasting glucose and HbA1c levels. Logistic regression analysis was used to evaluate which glucometabolic factor has the strongest correlation with CAD severity.

Results

HbA1c was the only glucometabolic factor associated with SYNTAX score above 22 (OR = 3.03, CI 95 % 1.03–8.9, p = 0.04). HbA1c was also significantly associated with CAD severity in subgroup analysis (MI and stable angina).

Conclusions

In non-diabetic patients with myocardial infarction or stable angina, HbA1c levels correlate with CAD severity as measured by the SYNTAX score. No correlation was found between admission glucose or fasting glucose levels and CAD severity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M (2008) Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care 31(Suppl 2):S155–S160

    Article  CAS  PubMed  Google Scholar 

  2. Giugliano D, Ceriello A, Esposito K (2008) Glucose metabolism and hyperglycemia. Am J Clin Nutr 87:217S–222S

    CAS  PubMed  Google Scholar 

  3. Peter P, Nuttall SL, Kendall MJ (2003) Insulin resistance—the new goal! J Clin Pharm Ther 28:167–174

    Article  CAS  PubMed  Google Scholar 

  4. Farhan S, Jarai R, Tentzeris I, Kautzky-Willer A, Samaha E, Smetana P, Jakl-Kotauschek G, Wojta J, Huber K (2012) Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease. Clin Res Cardiol 101:625–630

    Article  CAS  PubMed  Google Scholar 

  5. De Caterina R, Madonna R, Sourij H, Wascher T (2010) Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options. Eur Heart J 31:1557–1564

    Article  PubMed  Google Scholar 

  6. Arbel Y, Rind E, Banai S, Halkin A, Berliner S, Herz I, Mashav N, Thurm T, Keren G, Finkelstein A (2012) Prevalence and predictors of slow flow in angiographically normal coronary arteries. Clin Hemorheol Microcirc 52:5–14

    PubMed  Google Scholar 

  7. Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, Shevach A, Berliner S, Herz I, Keren G (2012) Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis 225(2):456–460

    Article  CAS  PubMed  Google Scholar 

  8. Arbel Y, Banai S, Benhorin J, Finkelstein A, Herz I, Halkin A, Keren G, Yedgar S, Barashtein G, Berliner S (2012) Erythrocyte aggregation as a cause of slow flow in patients of acute coronary syndromes. Int J Cardiol 154:322–327

    Article  PubMed  Google Scholar 

  9. Arbel Y, Halkin A, Finkelstein A, Revivo M, Berliner S, Herz I, Keren G, Banai S (2013) Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol 29(11):1374–1381

    Article  PubMed  Google Scholar 

  10. Ringqvist I, Fisher LD, Mock M, Davis KB, Wedel H, Chaitman BR, Passamani E, Russell RO Jr, Alderman EL, Kouchoukas NT, Kaiser GC, Ryan TJ, Killip T, Fray D (1983) Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 71:1854–1866

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW (2005) The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1:219–227

    PubMed  Google Scholar 

  12. Sadhu AR, Ang AC, Ingram-Drake LA, Martinez DS, Hsueh WA, Ettner SL (2008) Economic benefits of intensive insulin therapy in critically Ill patients: the targeted insulin therapy to improve hospital outcomes (TRIUMPH) project. Diabetes Care 31:1556–1561

    Article  PubMed Central  PubMed  Google Scholar 

  13. Verges B, Zeller M, Dentan G, Beer JC, Laurent Y, Janin-Manificat L, Makki H, Wolf JE, Cottin Y (2007) Impact of fasting glycemia on short-term prognosis after acute myocardial infarction. J Clin Endocrinol Metab 92:2136–2140

    Article  CAS  PubMed  Google Scholar 

  14. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, Markiewicz W, Aronson D (2005) Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111:754–760

    Article  CAS  PubMed  Google Scholar 

  15. Kolman L, Hu YC, Montgomery DG, Gordon K, Eagle KA, Jackson EA (2009) Prognostic value of admission fasting glucose levels in patients with acute coronary syndrome. Am J Cardiol 104:470–474

    Article  CAS  PubMed  Google Scholar 

  16. Jensen CJ, Eberle HC, Nassenstein K, Schlosser T, Farazandeh M, Naber CK, Sabin GV, Bruder O (2011) Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI. Clin Res Cardiol 100:649–659

    Article  CAS  PubMed  Google Scholar 

  17. Dziewierz A, Giszterowicz D, Siudak Z, Rakowski T, Dubiel JS, Dudek D (2010) Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol 99:715–721

    Article  PubMed  Google Scholar 

  18. Yang Z, Laubach VE, French BA, Kron IL (2009) Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion. J Thorac Cardiovasc Surg 137:723–729

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Ceriello A (2008) Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings. Diabet Vasc Dis Res 5:260–268

    Article  Google Scholar 

  20. Zarich SW, Nesto RW (2007) Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 115:e436–e439

    Article  PubMed  Google Scholar 

  21. Bauters C, Ennezat PV, Tricot O, Lauwerier B, Lallemant R, Saadouni H, Quandalle P, Jaboureck O, Lamblin N, Le Tourneau T (2007) Stress hyperglycaemia is an independent predictor of left ventricular remodelling after first anterior myocardial infarction in non-diabetic patients. Eur Heart J 28:546–552

    Article  CAS  PubMed  Google Scholar 

  22. Yosefy C (2003) Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved? Acta Diabetol 40(Suppl 2):S380–S388

    Article  PubMed  Google Scholar 

  23. Akalin A, Temiz G, Akcar N, Sensoy B (2008) Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes. Endocr J 55(5):861–866

    Article  CAS  PubMed  Google Scholar 

  24. Timmer JR, Ottervanger JP, Bilo HJ, Dambrink JH, Miedema K, Hoorntje JC, Zijlstra F (2006) Prognostic value of admission glucose and glycosylated haemoglobin levels in acute coronary syndromes. QJM: Mon J Assoc Physicians 99:237–243

    Article  CAS  Google Scholar 

  25. Karabulut A, Iltumur K, Toprak N, Tuzcu AK, Kara IH, Kaplan A, Aksu Y (2005) Insulin response to oral glucose loading and coronary artery disease in nondiabetics. Int Heart J 46:761–770

    Article  PubMed  Google Scholar 

  26. Geisler T, Mueller K, Aichele S, Bigalke B, Stellos K, Htun P, Ninci E, Fateh-Moghadam S, May AE, Gawaz M (2010) Impact of inflammatory state and metabolic control on responsiveness to dual antiplatelet therapy in type 2 diabetics after PCI: prognostic relevance of residual platelet aggregability in diabetics undergoing coronary interventions. Clin Res Cardiol 99:743–752

    Article  PubMed  Google Scholar 

  27. Hartge MM, Unger T, Kintscher U (2007) The endothelium and vascular inflammation in diabetes. Diabet Vasc Dis Res 4:84–88

    Article  Google Scholar 

  28. Oswald GA, Yudkin JS (1987) Hyperglycaemia following acute myocardial infarction: the contribution of undiagnosed diabetes. Diabet Med 4:68–70

    Article  CAS  PubMed  Google Scholar 

  29. Ilany J, Marai I, Cohen O, Matetzky S, Gorfine M, Erez I, Hod H, Karasik A (2009) Glucose homeostasis abnormalities in cardiac intensive care unit patients. Acta Diabetol 46:209–216

    Article  CAS  PubMed  Google Scholar 

  30. Anantharaman R, Heatley M, Weston CF (2009) Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target? Heart 95:697–703

    Article  CAS  PubMed  Google Scholar 

  31. Undas A, Wiek I, Stepien E, Zmudka K, Tracz W (2008) Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome. Diabetes Care 31:1590–1595

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Gustafsson I, Kistorp CN, James MK, Faber JO, Dickstein K, Hildebrandt PR (2007) Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction. Am Heart J 154:470–476

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Cardiology, Tel Aviv Sourasky Medical Center, Affiliated to Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    Yaron Arbel, Margalit Zlotnik, Amir Halkin, Ofer Havakuk, Itzhak Herz, Itay Rabinovich, Gad Keren, Shmuel Bazan, Ariel Finkelstein & Shmuel Banai

  2. Department of Internal Medicine “D” and “E”, Tel Aviv Sourasky Medical Center, Affiliated to Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    Shlomo Berliner

Authors
  1. Yaron Arbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margalit Zlotnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amir Halkin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ofer Havakuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shlomo Berliner
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Itzhak Herz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Itay Rabinovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gad Keren
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shmuel Bazan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ariel Finkelstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Shmuel Banai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yaron Arbel.

Additional information

Y. Arbel and M. Zlotnik have contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arbel, Y., Zlotnik, M., Halkin, A. et al. Admission glucose, fasting glucose, HbA1c levels and the SYNTAX score in non-diabetic patients undergoing coronary angiography. Clin Res Cardiol 103, 223–227 (2014). https://doi.org/10.1007/s00392-013-0641-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-013-0641-7

Keywords

Search

Navigation